Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126510121 | 12651012 | 1 | I | 20160602 | 0 | 20160812 | 20160812 | DIR | 29.00 | YR | F | N | 116.00000 | LBS | 20160811 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126510121 | 12651012 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | N | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126510121 | 12651012 | 1 | Skin wrinkling |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126510121 | 12651012 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126510121 | 12651012 | Arthralgia | |
| 126510121 | 12651012 | Asthenia | |
| 126510121 | 12651012 | Blepharospasm | |
| 126510121 | 12651012 | Chest discomfort | |
| 126510121 | 12651012 | Dizziness | |
| 126510121 | 12651012 | Dry eye | |
| 126510121 | 12651012 | Eyelid ptosis | |
| 126510121 | 12651012 | Fatigue | |
| 126510121 | 12651012 | Headache | |
| 126510121 | 12651012 | Memory impairment | |
| 126510121 | 12651012 | Slow speech |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126510121 | 12651012 | 1 | 20160325 | 0 |